Endometrial polyps Uterine fibroids (particularly submucosal fibroids) Adenomyosis Endometrial hyperplasia and early-stage endometrial cancer Intrauterine adhesions (Asherman syndrome) Abnormal uterine bleeding
Conditions
Interventions
Group P:fospropofol for induction and maintenance of anesthesia
Group C:propofol for induction and maintenance of anesthesia
Sponsors
Dazhou Central Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Aged>=18 years; 2.American Society of Anesthesiologists (ASA) Physical Status Classification I-II; 3.Body Mass Index (BMI) 18-30 kg/m^2;
Exclusion criteria
Exclusion criteria: 1.Patients undergoing emergency surgery; 2.Patients with a history of soy product allergy; 3.Patients with a history of mental illness and long-term use of sedative, analgesic, or antipsychotic drugs; 4.Patients who have undergone major surgery (including cardiovascular surgery, neurosurgery, organ transplantation, etc.) within the past 2 years; 5.Patients with excessive alcohol consumption, severe visual or auditory impairment, or inability to complete the scoring assessment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PACU stay time; | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative Hemodynamics;Intraoperative Movement;endotracheal tube extubation time;Riker Sedation-Agitation Scale (RSAS);visual analogue scale;corneal reflex loss time;quality of recovery-40 questionnaire;postoperative eye opening time;Incidence of Delayed Complications at 48 Hours Post-surgery;Patient Satisfaction Score at 72 Hours Post-surgery;Safety Indicators;Total Dosage of Fospropofol Disodium / Propofol and Remifentanil; | — |
Countries
China
Contacts
Public ContactChao Liao
Dazhou Central Hospital
Outcome results
None listed